Company
Lexeo Therapeutics, Inc. (LXEO)
Standardized SEC financial data for Lexeo Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001907108 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-40.5%
Free cash flow
-$99.0M
Current ratio
11.21×
EPS (diluted)
$-1.86
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $654K | — | — | — |
| R&D expense | $49.2M | $53.1M | $74.1M | $63.8M |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $135.9M | $80.6M | $124.7M | $128.5M | $66.2M |
| Total current assets | — | $80.0M |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$54.6M | -$59.5M | -$81.2M | -$98.6M |
| Capital expenditures | $672K | $115K | $481K | $397K |
Get LXEO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LXEO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LXEO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"